Characterization of cAMP‐phosphodiesterase as a possible laboratory marker of atopic dermatitis
- 1 January 1988
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 13 (2-3) , 123-136
- https://doi.org/10.1002/ddr.430130205
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Human Basophil Releasability. II. Changes in Basophil Releasability in Patients with Atopic DermatitisJournal of Investigative Dermatology, 1986
- Dermal Deposition of Eosinophil-Granule Major Basic Protein in Atopic DermatitisNew England Journal of Medicine, 1985
- Phosphodiesterase Inhibition by Ro 20-1724 Reduces Hyper-IgE Synthesis by Atopic Dermatitis Cells In VitroJournal of Investigative Dermatology, 1985
- Elevated umbilical cord blood leukocyte cyclic adenosine monophosphate-phosphodiesterase activity in children with atopic parentsJournal of the American Academy of Dermatology, 1984
- Increased Plasma Histamine Concentrations after Food Challenges in Children with Atopic DermatitisNew England Journal of Medicine, 1984
- Occupational dermatoses in South Carolina: A descriptive analysis of cost variablesJournal of the American Academy of Dermatology, 1983
- Identification and properties of cyclic nucleotide phosphodiesterasesMolecular and Cellular Endocrinology, 1982
- Elevated leukocyte cyclic AMP—phosphodiesterase in atopic disease: a possible mechanism for cyclic AMP—agonist hyporesponsivenessJournal of Allergy and Clinical Immunology, 1982
- Heterologous desensitization of leukocytes: a possible mechanism of beta adrenergic blockade in atopic dermatitisJournal of Allergy and Clinical Immunology, 1981
- The beta adrenergic theory of the atopic abnormality in bronchial asthmaJournal of Allergy, 1968